Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DAYBUE or DAYBUE STIX safely and effectively. See full prescribing information for DAYBUE and DAYBUE STIX. DAYBUE® (trofinetide) oral solution DAYBUE® STIX (trofinetide) for oral solutionInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
DAYBUE and DAYBUE STIX are indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.
- generic_name
- trofinetide
- product_names
- trofinetide
- ndc
- 63090-660, 63090-660-01, 63090-663, 63090-663-01, 63090-663-60, 63090-664, 63090-664-01, 63090-664-60, 63090-665, 63090-665-01, 63090-665-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en